Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
15.85
+2.39 (17.76%)
At close: Feb 18, 2025, 4:00 PM
16.57
+0.72 (4.54%)
Pre-market: Feb 19, 2025, 5:54 AM EST
Oscar Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Oscar Health stock have an average target of 21.56, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 36.03% from the current stock price of 15.85.
Analyst Consensus: Hold
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for Oscar Health stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 2 | 3 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 1 | 2 | 2 | 2 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Sell Initiates $12 | Sell | Initiates | $12 | -24.29% | Dec 10, 2024 |
B of A Securities | B of A Securities | Hold → Sell Downgrades $21 → $14 | Hold → Sell | Downgrades | $21 → $14 | -14.83% | Nov 6, 2024 |
UBS | UBS | Hold Initiates $23 | Hold | Initiates | $23 | +45.11% | Oct 7, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $28 | Buy | Reiterates | $28 | +76.66% | Sep 10, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +76.66% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
11.35B
Revenue Next Year
11.00B
from 11.35B
Decreased by -3.13%
EPS This Year
0.76
from 0.10
Increased by 657.72%
EPS Next Year
0.87
from 0.76
Increased by 15.32%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 11.9B | 12.1B | 14.7B |
Avg | 11.4B | 11.0B | 13.4B |
Low | 10.4B | 9.8B | 11.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 6.3% | 33.8% |
Avg | - | -3.1% | 21.5% |
Low | - | -13.6% | 0.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.92 | 1.42 | 2.36 |
Avg | 0.76 | 0.87 | 1.64 |
Low | 0.59 | 0.39 | 1.17 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 824.0% | 87.1% | 170.4% |
Avg | 657.7% | 15.3% | 88.2% |
Low | 488.0% | -48.3% | 33.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.